thyroxine has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nisman, B | 1 |
| Allweis, TM | 1 |
| Carmon, E | 1 |
| Kadouri, L | 1 |
| Maly, B | 1 |
| Maimon, O | 1 |
| Meirovitz, A | 1 |
| Peretz, T | 1 |
1 other study available for thyroxine and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Elevated Free Triiodothyronine Is Associated With Increased Proliferative Activity in Triple-negative Breast Cancer.
Topics: Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Middle Aged; Thymidine K | 2021 |